Skip to main content
Caplight Logo









Anokion

Anokion

Private
EcublensHealthcare & Life Scienceshttps://anokion.com

Last Round

Corporate Funding

Oct 18, 2022

Total Funding Raised

$112.5M

Company Overview

Anokion is a biotechnology company that develops antigen-specific immunotherapy aimed at promoting immune tolerance for various autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immune toleranceautoimmune therapybiotechnologyantigen-specific therapyclinical-stage biotechdrug discoveryimmunologytherapeutic platformclinical trialsbiopharma partnershipimmune modulationtolerogenic therapynext-gen immunologyliver-targeted therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anokion Comparables

Compare Anokion with similar companies based on industry and business-model similarity.

Anokion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Parvus Therapeutics Inc.
87%
Worg Pharmaceuticals
83%
AnTolRx, Inc.
83%

Anokion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingOct 18, 2022
Series BSep 11, 2019
Series AMay 5, 2014

Anokion Investors

Notable investors and investment history

Anokion investors
InvestorRounds
Novo VenturesSeries B, Series A
Versant VenturesSeries B, Series A
Novo HoldingsSeries B, Series A
PfizerCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2014

    $38M round led by Novartis and Versant Ventures.

Anokion Filings

Explore SEC and related filing metadata, where available.

Anokion filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anokion's valuation, stock price, and market status.

Is Anokion a public or private company?

Anokion is a private company.

What is the current stock price of Anokion?

Anokion is a private company with no public stock price. No recent secondary market data is available.

How much is Anokion worth (valuation)?

Valuation information for Anokion is not publicly available.

Can I buy Anokion stock?

Anokion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anokion's last funding round?

Anokion's most recent funding round was VC Round on October 18, 2022.

Who are the main investors in Anokion?

Key investors in Anokion include Versant Ventures, Pfizer.

Will Anokion IPO soon?

No public IPO plans have been announced for Anokion.

How can I track Anokion secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anokion's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEcublens
Employee Range13
Year Founded2010
Last FundingOct 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?